European Leukemia Trial Registry
Trial: PACE

More Details
Title ACE-536 for the Treatment of Anemia in MDS
Scientific Title A Phase 2, Open Label, Ascending Dose Study of ACE-536 for the Treatment of Anemia in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Short Title PACE
Trialgroup NN
Type of Trial single-group, open-label
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Age >= 18 years
Status Active
Start of Recruitment 01.01.2013
Leader Platzbecker, Prof. Dr. med., Uwe
Shortprotocol Shortprotocol
created 10.04.2013 Johannes Kraus
changed 15.04.2013 Sina Hehn
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org